Nexia Health Technologies Inc. does not have any significant operations. More Details
Worrying balance sheet with weak fundamentals.
Share Price & News
How has Nexia Health Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NGH.H has not had significant price volatility in the past 3 months.
7 Day Return
CA Healthcare Services
1 Year Return
CA Healthcare Services
Return vs Industry: NGH.H underperformed the Canadian Healthcare Services industry which returned 33% over the past year.
Return vs Market: NGH.H exceeded the Canadian Market which returned -5.7% over the past year.
Price Volatility Vs. Market
How volatile is Nexia Health Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 months ago | Simply Wall StNexia Health Technologies (CVE:NGH.H) Will Have To Spend Its Cash Wisely
7 months ago | Simply Wall StHere's Why Nexia Health Technologies (CVE:NGH.H) Must Use Its Cash Wisely
11 months ago | Simply Wall StWill Nexia Health Technologies (CVE:NGH.H) Spend Its Cash Wisely?
Is Nexia Health Technologies undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Nexia Health Technologies is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nexia Health Technologies has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
- Take a look at our analysis of NGH.H's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Nexia Health Technologies regulatory filings.
- Explore potentially undervalued companies in the Healthcare industry.
How is Nexia Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nexia Health Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of NGH.H’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Nexia Health Technologies competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Nexia Health Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NGH.H is currently unprofitable.
Growing Profit Margin: NGH.H is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NGH.H is unprofitable, and losses have increased over the past 5 years at a rate of 5.6% per year.
Accelerating Growth: Unable to compare NGH.H's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NGH.H is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).
Return on Equity
High ROE: NGH.H's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is Nexia Health Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: NGH.H has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NGH.H has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NGH.H is debt free.
Reducing Debt: NGH.H's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if NGH.H has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NGH.H has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Nexia Health Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NGH.H's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NGH.H's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NGH.H's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NGH.H's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NGH.H's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Azmin Daya has been Chief Executive Officer and President at Nexia Health Technologies Inc. since Februbary 01, 2019. Mr. Daya has been a Management Consultant (self-employed) since 2010. Mr. Daya serv ...
|CEO, President & Director||1.67yrs||CA$23.25k||no data|
|Independent Director||4.08yrs||CA$21.25k||0.12% |
Experienced Board: NGH.H's board of directors are considered experienced (4.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Nexia Health Technologies Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Nexia Health Technologies Inc.
- Ticker: NGH.H
- Exchange: TSXV
- Founded: 2002
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: CA$473.794k
- Shares outstanding: 94.76m
- Website: https://www.nexiahealth.com
- Nexia Health Technologies Inc.
- 15 Allstate Parkway
- 6th Floor
- L3R 5B4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NGH.H||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Sep 2005|
Nexia Health Technologies Inc. does not have any significant operations. Previously, it was engaged in the development, sale, and support of application software and related services to customers in the he ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/03 23:41|
|End of Day Share Price||2020/07/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.